🔎 Trials Near Me

Home › Head and Neck Cancer › NCT07318220

Prehabilitation Protocol for Head and Neck Cancer Patients

RecruitingHealthy volunteers welcome

Optimizing Cancer Support Services Usage in Patients With Head and Neck Cancer During the Prehabilitation Period

Who can join

Ages 18 to 80 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Aim 2 Inclusion Criteria: Implement prehabilitation prescription protocol and evaluate the feasibility and acceptability of the prehabilitation prescription protocol in a sample of HNC patients.

1. Age 18 to 80 years old
2. Patients with a diagnosis of squamous cell carcinoma originating in the head and neck (oral cavity, oropharynx, hypopharynx, larynx, and nasopharynx).
3. Stage I-III or de novo Stage IV
4. Patients with a plan for radiation therapy (RT) / chemoradiation therapy (CRT) at SCCC\* - \*Patients who underwent surgery for the HNC are still eligible.
5. If this is a second primary squamous cell carcinoma originating in the head and neck, a patient is eligible if the last RT or CRT was completed more than 6 months ago.
6. Clearance for exercise by the medical team.
7. Patients who do not have their first treatment scheduled within 7 days at the time of recruitment.
8. An English or Spanish speaker.

Aim 2 Exclusion Criteria:

1. A patient who cannot complete the baseline assessment and/or start prehabilitation by the initiation of RT/CRT.
2. Any contraindication for diet change or exercising as determined by a physician.
3. A patient who is not an English or Spanish speaker.
4. History of dementia or major psychiatric disease which would interfere with study.
5. History of recent (≤1 yr) stroke, myocardial infarction, or congestive heart failure
6. Eastern Cooperative Oncology Group (ECOG) equal to or higher than 2.

About the study

The purpose of this research is to help researchers understand the barriers, supports, and preferences for prehabilitation. Prehabilitation in this study means head and neck cancer patients will receive nutritional counseling sessions and attend exercise programs before and during radiotherapy/chemoradiotherapy treatment.

What is being tested

Sponsor: University of Miami · Participants: 60 · Started: May 1, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07318220

Locations in the U.S.

FloridaUniversity of Miami, Miami

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.